Effect of all-trans retinoic acid (ATRA) on syndecan-1 expression and its chemoprotective effect in benzo(α)pyrene-induced lung cancer mice model

References

• Yang, J., Lam, E.W., Hammad, H.M., Oberley, T.D., Oberley, L.W. Antioxidant enzyme levels in oral squamous cell carcinoma and normal human oral epithelium. J Oral Pathol Med 2002, 31, 71–77.
   PubMed Web of Science ®Google Scholar
• Stellman, S.D., Takezaki, T., Wang, L., Chen, Y., Citron, M.L., Djordjevic, M.V., Harlap, S., Muscat, J.E., Neugut, A.I., Wynder, E.L., Ogawa, H., Tajima, K., Aoki, K. Smoking and lung cancer risk in American and Japanese men: an international case-control study. Cancer Epidemiol Biomarkers Prev 2001, 10, 1193–1199.
   PubMed Web of Science ®Google Scholar
• Parkin, D.M., Bray, F., Ferlay, J., Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55, 74–108.
   PubMed Web of Science ®Google Scholar
• Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59, 225–249.
   PubMed Web of Science ®Google Scholar
• Hecht, S.S., Upadhyaya, P., Wang, M., Bliss, R.L., McIntee, E.J., Kenney, P.M. Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination. Carcinogenesis 2002, 23, 1455–1461.
   PubMed Web of Science ®Google Scholar
• Sticha, K.R., Staretz, M.E., Wang, M., Liang, H., Kenney, P.M., Hecht, S.S. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse. Carcinogenesis 2000, 21, 1711–1719.
   PubMed Web of Science ®Google Scholar
• Zheng, Y., Kramer, P.M., Lubet, R.A., Steele, V.E., Kelloff, G.J., Pereira, M.A. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 1999, 20, 255–260.
   PubMed Web of Science ®Google Scholar
• Wakino, S., Kintscher, U., Kim, S., Jackson, S., Yin, F., Nagpal, S., Chandraratna, R.A., Hsueh, W.A., Law, R.E. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Arterioscler Thromb Vasc Biol 2001, 21, 746–751.
   PubMed Web of Science ®Google Scholar
• Suzui, M., Masuda, M., Lim, J.T., Albanese, C., Pestell, R.G., Weinstein, I.B. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Res 2002, 62, 3997–4006.
   PubMed Web of Science ®Google Scholar
• Crowe, D.L., Kim, R., Chandraratna, R.A. Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway. Mol Cancer Res 2003, 1, 532–540.
   PubMed Web of Science ®Google Scholar
• Gumireddy, K., Sutton, L.N., Phillips, P.C., Reddy, C.D. All-trans-retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway. Clin Cancer Res 2003, 9, 4052–4059.
   PubMed Web of Science ®Google Scholar
• Nadauld, L.D., Sandoval, I.T., Chidester, S., Yost, H.J., Jones, D.A. Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebrafish intestinal development and differentiation. J Biol Chem 2004, 279, 51581–51589.
   PubMed Web of Science ®Google Scholar
• Siddikuzzaman, Guruvayoorappan C, Berlin Grcae VM. All trans retinoic acid and cancer. Immunopharmacol Immunotoxicol 2011; 33, 241–249.
   PubMed Web of Science ®Google Scholar
• Leder, A., Kuo, A., Cardiff, R.D., Sinn, E., Leder, P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 1990, 87, 9178–9182.
   PubMed Web of Science ®Google Scholar
• Chen, Z.X., Xue, Y.Q., Zhang, R., Tao, R.F., Xia, X.M., Li, C., Wang, W., Zu, W.Y., Yao, X.Z., Ling, B.J. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991, 78, 1413–1419.
   PubMed Web of Science ®Google Scholar
• Lallemand-Breitenbach, V., Guillemin, M.C., Janin, A., Daniel, M.T., Degos, L., Kogan, S.C., Bishop, J.M., de Thé, H. Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med 1999, 189, 1043–1052.
   PubMed Web of Science ®Google Scholar
• Gamage, S.D., Bischoff, E.D., Burroughs, K.D., Lamph, W.W., Gottardis, M.M., Walker, C.L., Fuchs-Young, R. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma. J Pharmacol Exp Ther 2000, 295, 677–681.
   PubMed Web of Science ®Google Scholar
• Kelly, W.K., Osman, I., Reuter, V.E., Curley, T., Heston, W.D., Nanus, D.M., Scher, H.I. The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer. Clin Cancer Res 2000, 6, 838–846.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Soprano, D.R., Parekh, H.K. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res 2001, 61, 7552–7555.
   PubMed Web of Science ®Google Scholar
• Wu, Q., Chen, Z., Su, W. Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression. Chin Med J 2001, 114, 958–961.
   PubMed Web of Science ®Google Scholar
• Chun, K.H., Benbrook, D.M., Berlin, K.D., Hong, W.K., Lotan, R. The synthetic heteroarotinoid SHetA2 induces apoptosis in squamous carcinoma cells through a receptor-independent and mitochondria-dependent pathway. Cancer Res 2003, 63, 3826–3832.
   PubMed Web of Science ®Google Scholar
• Lango, M., Wentzel, A.L., Song, J.I., Xi, S., Johnson, D.E., Lamph, W.W., Miller, L., Grandis, J.R. Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells. Clin Cancer Res 2003, 9, 4205–4213.
   PubMed Web of Science ®Google Scholar
• Manor, D., Shmidt, E.N., Budhu, A., Flesken-Nikitin, A., Zgola, M., Page, R., Nikitin, A.Y., Noy, N. Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Res 2003, 63, 4426–4433.
   PubMed Web of Science ®Google Scholar
• Czeczuga-Semeniuk, E., Anchim, T., Dzieciol, J., Dabrowska, M., Wolczynski, S. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells? Acta Biochim Pol 2004, 51, 733–745.
   PubMed Web of Science ®Google Scholar
• Liu, W.J., Zhang, Y.W., Zhang, Z.X., Ding, J. Alternative splicing of human telomerase reverse transcriptase may not be involved in telomerase regulation during all-trans-retinoic acid-induced HL-60 cell differentiation. J Pharmacol Sci 2004, 96, 106–114.
   PubMed Web of Science ®Google Scholar
• Dahl, A.R., Grossi, I.M., Houchens, D.P., Scovell, L.J., Placke, M.E., Imondi, A.R., Stoner, G.D., De Luca, L.M., Wang, D., Mulshine, J.L. Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res 2000, 6, 3015–3024.
   PubMed Web of Science ®Google Scholar
• Chang, Y.S., Chung, J.H., Shin, D.H., Chung, K.Y., Kim, Y.S., Chang, J., Kim, S.K., Kim, S.K. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium. Yonsei Med J 2004, 45, 435–442.
   PubMed Web of Science ®Google Scholar
• Chansri, N., Kawakami, S., Yamashita, F., Hashida, M. Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice. Int J Pharm 2006, 321, 42–49.
   PubMed Web of Science ®Google Scholar
• Tkachenko, E., Rhodes, J.M., Simons, M. Syndecans: new kids on the signaling block. Circ Res 2005, 96, 488–500.
   PubMed Web of Science ®Google Scholar
• Sun, W.P., Wang, F.M., Xie, F., Wang, G.Q., Sun, J., Yu, G.H., Qiu, Y.H., Zhang, X.G. A novel anti-human syndecan-1 (CD138) monoclonal antibody 4B3: characterization and application. Cell Mol Immunol 2007, 4, 209–214.
   PubMed Web of Science ®Google Scholar
• Hirabayashi, K., Numa, F., Suminami, Y., Murakami, A., Murakami, T., Kato, H. Altered proliferative and metastatic potential associated with increased expression of syndecan-1. Tumour Biol 1998, 19, 454–463.
   PubMedGoogle Scholar
• Kodama J, Kusumoto T, Shinyo Y, Seki N, Hiramatsu Y. Prognostic significance of syndecan-1 expression in human endometrial cancer. Annals Oncol 2005, 4, 1109–1115.
   Google Scholar
• Yang, Y., Macleod, V., Miao, H.Q., Theus, A., Zhan, F., Shaughnessy, J.D. Jr, Sawyer, J., Li, J.P., Zcharia, E., Vlodavsky, I., Sanderson, R.D. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J Biol Chem 2007, 282, 13326–13333.
   PubMed Web of Science ®Google Scholar
• Yan, Y., Wang, Y., Tan, Q., Lubet, R.A., You, M. Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice. Neoplasia 2005, 7, 1053–1057.
   PubMed Web of Science ®Google Scholar
• Suzuki, S., Kawakami, S., Chansri, N., Yamashita, F., Hashida, M. Inhibition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes. J Control Release 2006, 116, 58–63.
   PubMed Web of Science ®Google Scholar
• Drabkin DL, Austin JM. Spectrometric studies; spectrometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem 1932, 98, 719–733.
   Google Scholar
• Booran GA, Eustis SL, Elwell MR, Montgory CA, McKenzie WF, ed. (1990). Pathology of the Fisher Rat. San Diego: Academic Press, 405–418.
   Google Scholar
• Wiethege, T., Voss, B., Müller, K.M. P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer. J Cancer Res Clin Oncol 1995, 121, 371–377.
   PubMed Web of Science ®Google Scholar
• Prakash J, Guptha SK, Kochupillai V, Singh N, Gupta YK, Joshi S. Chemopreventive activity of Withania somnifera in experimentally-induced fibrosarcoma tumours in Swiss albino mice. Phytother Res 2000; 14, 1–6.
   PubMedGoogle Scholar
• Davis, L., Kuttan, G. Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 2000, 71, 193–200.
   PubMed Web of Science ®Google Scholar
• Douer, D., Koeffler, H.P. Retinoic acid enhances growth of human early erythroid progenitor cells in vitro. J Clin Invest 1982, 69, 1039–1041.
   PubMed Web of Science ®Google Scholar
• Tobler, A., Dawson, M.I., Koeffler, H.P. Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro. J Clin Invest 1986, 78, 303–309.
   PubMed Web of Science ®Google Scholar
• Smeland, E.B., Rusten, L., Jacobsen, S.E., Skrede, B., Blomhoff, R., Wang, M.Y., Funderud, S., Kvalheim, G., Blomhoff, H.K. All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cells. Blood 1994, 84, 2940–2945.
   PubMedGoogle Scholar
• Rusten, L.S., Dybedal, I., Blomhoff, H.K., Blomhoff, R., Smeland, E.B., Jacobsen, S.E. The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells. Blood 1996, 87, 1728–1736.
   PubMed Web of Science ®Google Scholar
• Li, S., Yan, T., Yang, J.Q., Oberley, T.D., Oberley, L.W. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 2000, 60, 3927–3939.
   PubMed Web of Science ®Google Scholar
• Inki, P., Joensuu, H., Grénman, R., Klemi, P., Jalkanen, M. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 1994, 70, 319–323.
   PubMed Web of Science ®Google Scholar
• Pulkkinen, J.O., Penttinen, M., Jalkanen, M., Klemi, P., Grénman, R. Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol 1997, 117, 312–315.
   PubMed Web of Science ®Google Scholar
• Iozzo, R.V., Cohen, I. Altered proteoglycan gene expression and the tumor stroma. Experientia 1993, 49, 447–455.
   PubMedGoogle Scholar
• Kato, M., Saunders, S., Nguyen, H., Bernfield, M. Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol Biol Cell 1995, 6, 559–576.
   PubMed Web of Science ®Google Scholar
• Inki, P., Stenbäck, F., Talve, L., Jalkanen, M. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation. Am J Pathol 1991, 139, 1333–1340.
   PubMed Web of Science ®Google Scholar
• Inki, P., Jalkanen, M. The role of syndecan-1 in malignancies. Ann Med 1996, 28, 63–67.
   PubMed Web of Science ®Google Scholar
• Mukunyadzi, P., Liu, K., Hanna, E.Y., Suen, J.Y., Fan, C.Y. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma. Mod Pathol 2003, 16, 796–801.
   PubMedGoogle Scholar
• Bayer-Garner, I.B., Sanderson, R.D., Smoller, B.R. Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma. J Cutan Pathol 1999, 26, 386–390.
   PubMed Web of Science ®Google Scholar